Stenting in small coronary arteries (SISCA) trial
A randomized comparison between balloon angioplasty and the heparin-coated beStent
Rasmus Moer, MD*,*,
Yngvar Myreng, MD, PhD*,
Per Mølstad, MD, PhD*,
Per Albertsson, MD, PhD ,
P.ål Gunnes, MD, PhD ,
Bo Lindvall, MD ,
Rune Wiseth, MD, PhD||,
Kjetil Ytre-Arne, MD*,
John Kjekshus, MD, PhD¶ and
Svein Golf, MD, PhD*
* Department of Cardiology, The Feiring Heart Clinic, Feiring, Norway
Division of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Cardiology, Tromsø University Hospital, Tromsø, Norway
Department of Radiology/Cardiology, Huddinge University Hospital, Stockholm, Sweden
|| Division of Cardiology, University Hospital of Trondheim, Norwegian University of Science and Technology, Trondheim, Norway
¶ Department of Cardiology, National Hospital, Oslo, Norway

View larger version (13K):
[in a new window]
|
Figure 1 Kaplan-Meier plot of event-free survival (p = 0.016 by the log-rank test). Solid line = beStent; dashed line = balloon angioplasty.
|
|
|